Delivery Order SPE2DB25D3110-SPE2DB25FTEEQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,868.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,138.88 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,570.39 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order, which carries no set-aside designation, will be performed at the contractor's Conshohocken, Pennsylvania facility. As a child delivery order under a larger contract vehicle, this award represents a specific pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens valued at $5,236.50 on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,970.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and carries firm fixed pricing with no set-aside designation. The award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a ceiling value of $1,735.26. This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,584.22 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance to be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified pharmaceutical distributors....
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEEQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor will fulfill the order from its Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. This delivery order is part of AmerisourceBergen's comprehensive global pharmaceutical support arrangement with DLA, which enables the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Trulicity, a brand-name diabetes medication, represents one of many specialty pharmaceutical products the contractor routinely delivers through the SPE2DX vehicle. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen has demonstrated consistent capability to meet DLA requirements through open competition, with its contract portfolio spanning multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/25/25 |